HIGHLIGHTS
- who: David Pu00e9ricat et al. from the Institute of Pharmacology and Structural Biology (IPBS), University of Toulouse, CNRS, Toulouse, France have published the article: Antiviral and Anti-Inflammatory Activities of Fluoxetine in a SARS-CoV-2 Infection Mouse Model, in the Journal: (JOURNAL)
- what: In this report, the authors show that fluoxetine has both significant anti-viral and anti-in
- how: In this report the authors evaluated the potential and activities of fluoxetine in a K18-hACE2 mouse model of SARS-CoV-2 infection and against variants of concern in vitro i.e . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.